Wedbush Reiterates Outperform on Imax, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Alicia Reese reiterates an Outperform rating on Imax (NYSE:IMAX) and maintains a $22 price target.
February 23, 2024 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Alicia Reese reiterates an Outperform rating on Imax and maintains a $22 price target.
The reiteration of an Outperform rating and the maintenance of a $22 price target by a reputable analyst could positively influence investor sentiment towards IMAX, potentially leading to a short-term increase in its stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100